Human medicines European public assessment report (EPAR): Abseamed, epoetin alfa, Date of authorisation: 27/08/2007, Date of refusal: 18/06/2009, Revision: 26, Status: Authorised
SPOR and XEVMPD status update webinar, Broadcast, from 9 April 2025, 10:00 (CEST) to 9 April 2025, 12:30 (CEST)
Q&A extract - SPOR and XEVMPD status update webinar 9 April 2025
PMS PUI Training: Product data submission & bulk edit made easy, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 October 2025, 10:00 (CEST) to 6 October 2025, 12:00 (CEST)
Human medicines European public assessment report (EPAR): Kayfanda, odevixibat, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7 – 10 July 2025
Ixchiq: temporary restriction on vaccinating people 65 years and older to be lifted
Human medicines European public assessment report (EPAR): Capecitabine Teva, capecitabine, Date of authorisation: 20/04/2012, Revision: 17, Status: Authorised
Sharing data across systems: Master data on human medicines
Review of artificial intelligence and machine learning applications in medicines lifecycle 2024: Horizon Scanning Short Report